ASCO GI 2021 | Real-world outcomes of second-line chemotherapy on advanced biliary tract and gallbladder cancers

Shahid Ahmed, PhD, MD, FRCPC, FACP, Saskatoon Cancer Center, University of Saskatchewan, Saskatoon, Canada, provides an update on the results of a multicenter retrospective population-based cohort study evaluating the impact of real-world second-line chemotherapy on survival in patients with advanced biliary tract and gallbladder cancers. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).